| 09:00 - 10:40 | Session 1: Imaging modalities | | |
| 09:05 | Multiparametric US application in liver | | A. Brodnjak, Maribor/SI |
| 09:30 | MDCT of the Liver | | G. Porrello, Palermo/IT |
| 09:55 | Liver MRI: Extracellular agents | | R. Cannella, Palermo/IT |
| 10:15 | Liver MRI: Hepato-biliary contrast agents | | N. Kartalis, Stockholm/SE |
| 10:35 | Q&A | | |
| 10:40 | Coffee break | | | |
| 11:00 - 12:45 | Interactive case discussions (3 x 30min) | | | |
| | Cases from my workstation with focus on MRI | | N. Kartalis, Stockholm/SE |
| | Cases from my workstation with focus on CT | | G. Porrello, Palermo/IT | |
| | Cases from my workstation with focus on US | | A. Brodnjak, Maribor/SI |
| 12:45 | Lunch break | | |
| 13:45 - 15:15 | Session 2: Focal and diffuse diseases in the non-cirrhotic liver | | |
| 13:45 | Benign lesions in the non-cirrhotic liver – value of hepato-biliary agents | | A. Calin- Vainak, Cluj-Napoca/RO |
| 14:10 | Vascular liver diseases | | G. Zamboni, Verona/IT |
| 14:35 | Biliary diseases: benign and malignant lesions | | T. Lauenstein, Düsseldorf/DE |
| | Q&A | | |
| 15:15 | Coffee break | | |
| 15:45 - 17:30 | Interactive case discussions (3 x 30min) | | |
| | Cases from the MDT Board: Biliary tumors | | T. Lauenstein, Düsseldorf/DE |
| | How MRI can help to characterize a lesion in the non-cirrhotic liver | | A. Calin- Vainak, Cluj-Napoca/RO |
| | Vascular liver diseases | | G. Zamboni, Verona/IT |
| 17:30 | Adjourn | | |
Friday, June 28, 2024 | |
|
| 08:30 - 09:55 | Session 4: HCC and fibrocystic diseases | | | |
| 08:30 | Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines | | M. Karçaaltıncaba, Ankara/TR |
| 08:55 | Focal lesions in cirrhosis: Not always HCC | | C. Caraiani, Cluj-Napoca/RO |
| 09:20 | Structured reports using LIRADS | | V. Bura, Cluj-Napoca/RO |
| 09:45 | Q&A | | |
| 09:55 | Coffee break | | | |
| 11:20 - 12:50 | Interactive case discussions (3 x 30min) | | | |
| | Practical guide to LIRADS | | V. Bura, Cluj-Napoca/RO |
| | Staging of HCC | | M. Karçaaltıncaba, Ankara/TR |
| | Differential diagnosis HCC – Regenerative Nodule | | R. Cannella, Palermo/IT |
| 12:00 | Lunch break | | | |
| 13:00- 13:50 | Session 5: Malignant Liver Diseases | | | |
| 13:00 | Liver metastases detection and staging prior to surgery: methods and problems | | J. Podgórska, Warsaw/PL |
| 13:25 | Liver Imaging in HCC after locoregional and systemic therapies | | M. Comsa, Cluj-Napoca/RO |
| 13:50 | Coffee break | | |
| 14:00 - 15:45 | Interactive case discussions (3 x 30min) | | |
| | Detection of focal liver lesions | | J. Podgórska, Warsaw/PL |
| | My hardest cases: Incidental lesions in the cirrhotic liver | | C. Caraiani, Cluj-Napoca/RO |
| | Response Assessment after local regional therapies | | M. Comsa, Cluj-Napoca/RO |
| 15:45 | Quiz Cases Incidental liver lesion A. Calin- Vainak, Cluj-Napoca/RO DD Regenerative nodule vs HCC C. Caraiani, Cluj-Napoca/RO Adenoma DD FNH I. Nygård, Bekkestua/ NO Biliary disease case T. Lauenstein, Düsseldorf/ DE Liver metastases J. Podgórska, Warsaw/PL | | A. Calin- Vainak, Cluj-Napoca/RO |
| 16:15 | Adjourn | | |
